Sodium 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetate monohydrate, its preparation and use

The present invention relates to the novel 3,4-dihydroquinazoline sodium 2-[(4

Saved in:
Bibliographic Details
Main Authors BUSCHMANN, Helmut, CERON BERTRAN, Jordi Carles, GOLDNER, Thomas
Format Patent
LanguageEnglish
Published 13.10.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to the novel 3,4-dihydroquinazoline sodium 2-[(4
Bibliography:Application Number: AU20210225364